Ignite Creation Date:
2024-05-06 @ 8:22 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02725996
Status:
UNKNOWN
Last Update Posted:
2017-04-25
First Post:
2016-03-28
Brief Title:
By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy
Sponsor:
Southwest Hospital China
Organization:
Southwest Hospital China
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2016-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To prove that the efficacy and safety of NK group is superior to non-treatment groupControl group in patient undergone curative resectionRFA or operation for hepatocellular carcinoma in China
Detailed Description:
No adjuvant therapy has been shown to extend the survival of patients with hepatocellular carcinoma receiving curative treatmentWe investigated whether injections of NK cells prolongs recurrence-free survival of patients after curative therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None